Boston Scientific Revenue Growth Rates (BSX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Boston Scientific Corporation  (NYSE: BSX)
 

BSX's Revenue Growth by Quarter and Year

Boston Scientific's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 5,442.00
1st Quarter March 5,204.00
FY 10,646.00

BSXs Annual Revenue
Boston Scientific's Revenue in the fiscal year 2025 $ 20,075.00 millions
Boston Scientific's Revenue in the fiscal year 2024 $ 16,747.00 millions
Boston Scientific's Revenue in the fiscal year 2023 $ 14,241.00 millions
Boston Scientific's Revenue in the fiscal year 2022 $ 12,683.00 millions
Boston Scientific's Revenue in the fiscal year 2021 $ 11,888.00 millions




BSX Revenue second quarter 2026 Y/Y Growth Comment
Boston Scientific Corporation achieved in the second quarter 2026, above Company average Revenue improvement of 7.53% year on year, to $ 5,442.00 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue growth. While Boston Scientific Corporation' s Revenue increase of 7.53% ranks overall at the positon no. 2029 in the second quarter 2026.


BSX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 15.9 % 22.44 % 14.86 %
3rd Quarter September - 20.34 % 19.34 % 11.26 %
2nd Quarter June 7.53 % 22.84 % 14.44 % 10.97 %
1st Quarter March 11.6 % 20.9 % 13.81 % 12 %
FY   - 19.87 % 17.6 % -

Financial Statements
Boston Scientific's second quarter 2026 Revenue $ 5,442.00 millions BSX's Income Statement
Boston Scientific's second quarter 2025 Revenue $ 5,061.00 millions Quarterly BSX's Income Statement


BSX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.36 % 8.36 % 5.61 %
3rd Quarter September - 0.08 % 2.16 % -2.03 %
2nd Quarter June 4.57 % 8.54 % 6.82 % 6.23 %
1st Quarter March -1.55 % 2.24 % 3.54 % 4.5 %
FY (Year on Year)   - 19.87 % 17.6 % -


Back to BSX Growth rate Comparisons >> Back to BSX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #312
Overall #2029

Revenue Y/Y Growth Statistics
High Average Low
37.53 % 6.88 % -25.46 %
(Dec 31 2019)   (Dec 31 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #312
Overall #2029
Revenue Y/Y Growth Statistics
High Average Low
37.53 % 6.88 % -25.46 %
(Dec 31 2019)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Boston Scientific's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
99.41 % 2.81 % -52.89 %
(Dec 31 2019)  


BSX's II. Quarter Q/Q Revenue Comment
Boston Scientific Corporation achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.57%, to $ 5,442.00 millions, from $5,204.00 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1190.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #177
Overall #1190
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #177
Overall #1190
Revenue Q/Q Growth Statistics
High Average Low
99.41 % 2.81 % -52.89 %
(Dec 31 2019)  


BSX's II. Quarter Q/Q Revenue Comment
Boston Scientific Corporation achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.57%, to $ 5,442.00 millions, from $5,204.00 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1190.


Boston Scientific's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 20,997.00 $ 20,616.00 $ 20,075.00 $ 19,350.00 $ 18,494.00
Y / Y Revenue Growth (TTM) 13.53 % 17.45 % 19.87 % 21.61 % 21.44 %
Year on Year Revenue Growth Overall Ranking # 797 # 875 # 712 # 828 # 848
Seqeuential Revenue Change (TTM) 1.85 % 2.69 % 3.75 % 4.63 % 5.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 2029 # 1856 # 482 # 1729 # 1687


Cumulative Revenue growth Comment
Assuming the Boston Scientific's fiscal year would have ended in Jun 30 2026, Boston Scientific would have reprted above average annual Revenue increase of 13.53% year on year, of $ 20,997 millions.
This marks a slow-down of the companys growth trends and from the 17.45% rise in Mar 31 2026.

In the Healthcare sector 166 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 797, from total ranking in previous quarter at 875.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 167
Overall # 797

Revenue TTM Y/Y Growth Statistics
High Average Low
37.53 %
 6.88 %
-25.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2029
Cumulative Revenue growth Comment
Assuming the Boston Scientific's fiscal year would have ended in Jun 30 2026, Boston Scientific would have reprted above average annual Revenue increase of 13.53% year on year, of $ 20,997 millions.
This marks a slow-down of the companys growth trends and from the 17.45% rise in Mar 31 2026.

In the Healthcare sector 166 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 797, from total ranking in previous quarter at 875.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 167
Overall # 797

Revenue TTM Y/Y Growth Statistics
High Average Low
37.53 %
6.88 %
-25.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2029




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BSX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions
Abbvie Inc 10.16%$ 10.160 millions
Concentra Group Holdings Parent Inc 10.03%$ 10.030 millions
Lemaitre Vascular Inc 10.02%$ 10.017 millions
Amneal Pharmaceuticals Inc 9.93%$ 9.934 millions
Merit Medical Systems Inc9.79%$ 9.792 millions
Idexx Laboratories Inc9.73%$ 9.728 millions
Lenz Therapeutics Inc 9.72%$ 9.720 millions


About Boston Scientific Revenue Growth Rates (BSX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Boston Scientific Corp (CIK 885725).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000885725-26-000053
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Boston Scientific Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.